Navigation Links
More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
Date:12/3/2008

solid tumors in conjunction with standard antineoplastic therapy; prostate cancer should have progressed after treatment with at least one hormonal therapy.

Zometa is contraindicated in patients with hypersensitivity to zoledronic acid or other bisphosphonates, or any of the excipients in the formulation of Zometa. Hypersensitivity reactions, including rare cases of urticaria and angioedema and very rare cases of anaphylactic reaction/shock, have been reported.

Due to the risk of clinically significant deterioration in renal function, which may progress to renal failure, single doses of Zometa should not exceed 4 mg, and the duration of infusion should be no less than 15 minutes. Risk factors for the deterioration of renal function include impaired baseline renal function and multiple cycles of bisphosphonate treatment.

Zometa is not recommended in patients with bone metastases with severe renal impairment. In patients with mild to moderate renal impairment at baseline, lower doses of Zometa are recommended based on calculated creatinine clearance. Before each Zometa dose, serum creatinine should be measured and treatment should be withheld for renal deterioration until serum creatinine has returned to within 10% of the baseline value.

Zometa should not be used during pregnancy. Women of childbearing potential should be advised to avoid becoming pregnant. If the patient becomes pregnant while taking this drug, the patient should be apprised of the potential harm to the fetus.

Osteonecrosis of the jaw (ONJ) has been reported predominantly in cancer patients treated with intravenous bisphosphonates, including Zometa. Many of these patients were also receiving chemotherapy and corticosteroids, which may be risk factors for ONJ. Post-marketing experience and the literature suggest a greater frequency of reports of ONJ based on tumor type (advanced brea
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
4. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
5. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
6. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. St. Jude Gene Study Reveals Basis of Anti-Cancer Drug Resistance in Childhood Leukemia
10. Protein Tomography(TM) Reveals Molecular Mode of Action of Humax-EGFr Published in PNAS
11. Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Engineered Technologies (HDT), a leader in the development ... for the mechanical development of the Modular Prosthetic ... technology that will give patients improved, dexterous control ... sense of touch. ,, As part of ... Prosthetics 2009 (RP2009) project, the MPL overcomes the ...
(Date:12/16/2009)... Dec. 16 DATATRAK International, Inc. ... focused on global eClinical solutions for the ... of its version 9.0 eClinical Software. ... for product and service delivery and introduces ... Knowledge(TM) offering: the DATATRAK Learning Center(TM) and ...
(Date:12/16/2009)... 16 Scientists at,deCODE genetics, Inc. (Nasdaq: ... of a version of a common single-letter variant ... a major impact on susceptibility to type 2,diabetes ... not only large, but unusual:,if an individual inherits ... of,T2D by more than 30% compared to those ...
Breaking Medicine Technology:HDT Develops Robotic Arm Technology for DARPA's Revolutionizing Prosthetics 2009 Program 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis 28RA 29 57901 1Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis 28RA 29 57901 2Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis 28RA 29 57901 3Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis 28RA 29 57901 4New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 1New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 2New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 3New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 4New Families and Work Institute Study Reveals Declines in the Health of American Workforce 57900 5Sirion Therapeutics Announces FDA Approval of Zirgan 28TM 29 28Ganciclovir Ophthalmic Gel 29 0 15 25 for Herpetic Keratitis 57895 1Sirion Therapeutics Announces FDA Approval of Zirgan 28TM 29 28Ganciclovir Ophthalmic Gel 29 0 15 25 for Herpetic Keratitis 57895 2Sirion Therapeutics Announces FDA Approval of Zirgan 28TM 29 28Ganciclovir Ophthalmic Gel 29 0 15 25 for Herpetic Keratitis 57895 3Sirion Therapeutics Announces FDA Approval of Zirgan 28TM 29 28Ganciclovir Ophthalmic Gel 29 0 15 25 for Herpetic Keratitis 57895 4
... Changes Affect Region with Higher Incidence of ... Hypertension in United ... innovator and leader of BioZ(R) impedance cardiography (ICG),technology, today announced ... (CMS) recently made changes to their,coverage policies that allowed expanded ...
... Cites Continuing Progress on Clinical and Preclinical Programs, ... (Amex: KAL; FWB: CA4), a developer of new ... diseases, is pleased to provide an,update covering its ... of 2007. "Callisto has made substantial progress ...
Other Medicine Technology:Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics' BioZ(R) ICG Technology 2Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics' BioZ(R) ICG Technology 3Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics' BioZ(R) ICG Technology 4Callisto Reports on Second-Quarter 2007 Milestones 2Callisto Reports on Second-Quarter 2007 Milestones 3Callisto Reports on Second-Quarter 2007 Milestones 4
(Date:12/16/2009)... companies through annual marketing campaign , ... ... the 2010 Genetown™ Hotbed Campaign as its largest ... is sponsored by MassBio and showcases 37 Massachusetts ... places each entity’s brand on an electronic and printed ...
(Date:12/16/2009)... SAN FRANCISCO, Dec. 16 Shoppers like ... States, Mexico or Argentina. But grocers have found ... Origin Labeling (COOL) laws requiring them to provide ... specific website at easyCOOLnow.com for easily ... COOL laws include provisions that require retailers of ...
(Date:12/16/2009)... -- New research published online, December 10, ... and molecules present in pistachios, have anti-inflammatory ... of an inflammatory marker known as "Ifit-2" ... is a complex biological response to harmful ... it underlies functional changes associated with many ...
(Date:12/16/2009)... shrouded man found in a tomb on the edge of ... case of leprosy. Details of the research will be published ... The molecular investigation was undertaken by Prof. Mark Spigelman and ... for the Study of Infectious and Tropical Diseases at the ... Vernon of Lakehead University, Canada, Prof. Azriel Gorski of New ...
(Date:12/16/2009)... when the families of sick and dying hospitalized children ... them? How do pediatricians respond to such personal requests? ... spirituality help some patients and families cope with serious ... always the families and patients who raise the issue ... current issue of Southern Medical Journal , Brandeis ...
Breaking Medicine News(10 mins):Health News:Thriving Bioscience Region Leaves Its Mark 2Health News:New Website Helps Grocers Comply With COOL Laws 2Health News:New Study Reveals Pistachios Have Anti-Inflammatory Properties 2Health News:New Study Reveals Pistachios Have Anti-Inflammatory Properties 3Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 2Health News:DNA of Jesus-era shrouded man in Jerusalem reveals earliest case of leprosy 3Health News:Prayer on the hospital floor 2
... Faculty grants from the California Institute for Regenerative Medicine, ... investigation ultimately aimed at developing treatment strategies for such ... and amyotrophic lateral sclerosis. , The UCSF grants, which ... total $13.7 million and are intended to support the ...
... Receive Community Service, Gastroenterology and ... Diversity ... (NPs) to take a proactive approach to improving health care,in ... Nurse Practitioner Healthcare Foundation (NPHF) offers scholarships to,NPs who are ...
... India and BALTIMORE, Aug. 19 Lupin Ltd.,announced today ... marketing agreement for the AeroChamber Plus(R) line of products ... Lupin,Pharmaceuticals, Inc., USA, will use its 50 person sales ... is a Valved Holding Chamber (VHC) device that is,used ...
... Alliance Announce Strategic Partnership to ... Protecting Privacy, Through an innovative public/private partnership, ... privacy management and clinical trials ... Mass., Aug. 19 Private Access,Inc., and Genetic Alliance, ...
... VIENNA, Va., Aug. 19 Prematics, Inc. is ... to the company,s executive,management team as vice president ... regionally focused roll-outs of Prematics, clinical IT services,that ... the,physician practice., (Logo: http://www.newscom.com/cgi-bin/prnh/20060623/PREMATICSLOGO ), ...
... MD, August 18, 2008Young researchers presented innovative, early-stage ... a collaborative project of the AUA Foundation and ... August 7-9, 2008. The AUA Foundation hosted the ... the most cutting-edge research in sexual medicine. ...
Other Medicine News:Health News:UCSF faculty receive $13.7M from CIRM for stem cell research 2Health News:UCSF faculty receive $13.7M from CIRM for stem cell research 3Health News:Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 2Health News:Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 3Health News:Nurse Practitioner Healthcare Foundation Awards Scholarships to Leaders in Nursing 4Health News:Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc. for AeroChamber Plus(R) Brand in the US - Extends its Franchise with Pediatricians 2Health News:VirtualHealth Technologies, Inc., Announces That Its Associate, Private Access, Will Be Partnering with Genetic Alliance To Accelerate Medical Research While Protecting Privacy 2Health News:VirtualHealth Technologies, Inc., Announces That Its Associate, Private Access, Will Be Partnering with Genetic Alliance To Accelerate Medical Research While Protecting Privacy 3Health News:VirtualHealth Technologies, Inc., Announces That Its Associate, Private Access, Will Be Partnering with Genetic Alliance To Accelerate Medical Research While Protecting Privacy 4Health News:Prematics Names Dean M. Panovich Vice President, Deployment 2Health News:New research on sexual function 2
... The DataMate Laser Sheeted ... consists of laser-printable sheets ... wristband and laser labels ... The wristbands clear, fold-over ...
Use these popular insert style bands to secure a bar code label inside the wristband pocket for maximum convenience and security....
... Wristbands and Tags print in mere ... transfer printers. Direct thermal printers use ... coating under the bands protective surface. ... transfer highly durable ink from a ...
... Perfect for use in settings where a ... infants and where an easy to apply but ... size can be selected to suit the child. ... used with a parents wristband to ensure proper ...
Medicine Products: